Prescription drug · ANDA
Moxifloxacin NDC 63629-8357
Moxifloxacin hydrochloride 400 mg/1 · Tablet, Film coated · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63629-8357-1 | 6362983570163629835701 | 7 TABLET, FILM COATED in 1 BOTTLE (63629-8357-1)Marketed from Sep 17, 2020 | |
| 63629-8357-2 | 6362983570263629835702 | 10 TABLET, FILM COATED in 1 BOTTLE (63629-8357-2)Marketed from Nov 5, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Moxifloxacin
- Generic name (nonproprietary)
- moxifloxacin
- Active ingredients
- Moxifloxacin hydrochloride — 400 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Bryant Ranch PrepackNDC labeler code 63629
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 076938
- Marketing start
- Listing expires
- Other FDA classes
- Fluoroquinolones (Chemical structure)
- Identifiers
- Product ID 63629-8357_27864513-a113-4ec1-9e78-41bc762172bcSPL ID 27864513-a113-4ec1-9e78-41bc762172bcSPL set ID d20ba997-30de-445c-8766-924112bd834aRxCUI 311787UNII C53598599T
- Pharmacologic class
- Fluoroquinolone Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463629835701followed by a unit qualifier and the quantityPackage 63629-8357-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Moxifloxacin tablet is a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age and older caused by designated susceptible bacteria, in the conditions listed below: Community Acquired Pneumonia ( 1.1 ) Skin and Skin Structure Infections: Uncomplicated (1.2 ) and Complicated (1.3) Complicated Intra-Abdominal Infections ( 1.4 ) Plague (1.5) Acute Bacterial Sinusitis ( 1.6 ) Acute Bacterial Exacerbation of Chronic Bronchitis (1.7 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of moxifloxacin tablets and other antibacterial drugs. Moxifloxacin tablets should be used only to treat or prevent infections that are proven or st…
Excerpt only. Read the full label for complete information.
About NDC 63629-8357
- What is NDC 63629-8357?
- 63629-8357 is the product NDC for Moxifloxacin, Moxifloxacin hydrochloride 400 mg/1 tablet, film coated, listed with the FDA by Bryant Ranch Prepack. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Moxifloxacin.
- What is the active ingredient?
- Moxifloxacin hydrochloride.
- Who is the labeler?
- Bryant Ranch Prepack, NDC labeler code 63629. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Moxifloxacin?
- 23 other product NDCs are listed under this name. See all Moxifloxacin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Moxifloxacin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Moxifloxacin | Moxifloxacin hydrochloride 400 mg/1 | Tablet, Film coatedOral | Macleods Pharmaceuticals Limited | 33342-322 | 33342-0322-0733342-0322-12 |
| Moxifloxacinmoxifloxacin hydrochloride | Moxifloxacin hydrochloride 400 mg/1 | Tablet, Film coatedOral | Solaris Pharma Corporation | 73473-903 | 73473-0903-30 |
| Moxifloxacin | Moxifloxacin hydrochloride monohydrate 5 mg/mL | Solution/ dropsOphthalmic | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0379 | 80425-0379-01 |
| Moxifloxacin | Moxifloxacin hydrochloride 400 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-845 | 31722-0845-0531722-0845-30 |
| Moxifloxacin | Moxifloxacin hydrochloride monohydrate 5 mg/mL | Solution/ dropsOphthalmic | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0239 | 80425-0239-01 |
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | Direct Rx | 72189-334 | 72189-0334-05 |
| Moxifloxacin | Moxifloxacin hydrochloride monohydrate 5 mg/mL | Solution/ dropsOphthalmic | Direct Rx | 72189-321 | 72189-0321-05 |
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | SolutionOphthalmic | Lupin Pharmaceuticals, Inc. | 68180-421 | 68180-0421-01 |
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | NorthStar Rx LLC | 16714-643 | 16714-0643-01 |
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | A-S Medication Solutions | 50090-8029 | 50090-8029-00 |
Other NDCs under ANDA 076938
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Moxifloxacin | Moxifloxacin hydrochloride 400 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Limited | 55111-112 |
| Moxifloxacin | Moxifloxacin hydrochloride 400 mg/1 | Tablet, Film coatedOral | PD-Rx Pharmaceuticals, Inc. | 72789-233 |